Discover how a novel nasal spray could revolutionize traumatic brain injury treatment by reducing neuroinflammation and ...

Nasal decongestants, often used during cold and allergy seasons, can negatively impact brain health when used long-term or in ...

A nasal spray being developed to target brain inflammation can also prove effective in treating traumatic brain injury (TBI) ...

Lupin gets USFDA nod for Ipratropium Bromide Nasal Solution (0.03%) under abbreviated new drug application (ANDA). The approved drug is a generic of Atrovent Nasal Spray (0.03%) (Boehringer Ingelheim ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

Glenmark Pharmaceutical Ltd.'s shares rose over 5% during trade on Monday, after the management highlighted a 300.2% sales growth in India in the third quarter. It also reported a profit during the ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.